>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

ASA to Congressional Negotiators: Now is the Time to Repeal SGR and IPAB

Friday, February 10, 2012

As Congress continues its deliberations on the Medicare Sustainable Growth Rate (SGR) and other issues related to H.R. 3630, the Temporary Payroll Tax Cut Continuation Act of 2011, ASA re-affirmed the specialty’s strong support for a full repeal of SGR.  ASA urged that the SGR be replaced with a new payment model that takes into account the specialty’s unique historical payment disparity known as the “33% problem.”  ASA further advocated tying the payment fixes to the immediate repeal of the Independent Payment Advisory Board (IPAB)—an unaccountable and unelected board created under the Patient Protection and Affordable Care Act with sweeping powers to mandate Medicare payment cuts.

To read the entire letter, click here

« Back to Washington Alerts